VC  KdT Ventures

http://www.kdtvc.com/





     Office Locations:

306 View St.
Black Mountain, NC 28711
Phone: 615-210-4979

 

Stages:

  • Early


 

Industries:

  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    KdT Ventures is an early stage venture capital fund investing at the intersection of frontier computational science and the life sciences (chemicals, agriculture, and medicine).


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Ally Gudeman Head of Operations
    Cain McClary MD Managing Partner and Founder
    Rima Chakrabarti MD Venture Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/24/2024


      Motif Neurotech


      TX


      $18,750,000


      Series A


      01/16/2024


      Zymochem


      CA


      $21,000,000


      Series A


      07/20/2023


      SURGE Therapeutics


      MA


      $32,000,000


      Series B


     

    Portfolio companies include:


      54gene


      Abridge


      Andes
        web link


      Azitra
        web link


      Braid


      Canaery


      Checkerspot
        web link


      Debut Biotech
        web link


      Dimension Inx
        web link


      Elegen


      Equii


      Faeth Therapeutics
        web link


      Hi Fidelity Genetics
        web link


      Marigold


      Motif Neurotech
        web link


      Parthenon Therapeutics
        web link


      Path AI


      Revel


      SeQure Dx
        web link


      Solugen


      SURGE Therapeutics
        web link


      Theator
        web link


      Xilis


      Zymochem
        web link


     

    Recent News: